Nguyen Anne X, Wu Albert Y
Faculty of Medicine, McGill University, Montréal, Quebec, Canada.
Department of Ophthalmology, Stanford University School of Medicine, Stanford, California, USA.
Ocul Immunol Inflamm. 2021 Jul 4;29(5):1023-1028. doi: 10.1080/09273948.2020.1726969. Epub 2020 Mar 11.
: While cannabis has the potential to reduce corneal pain, cannabinoids might induce side effects. This review article examines the effects of cannabinoids on the cornea. As more states and countries consider the legalization of adult cannabis use, health-care providers will need to identify ocular effects of cannabis consumption.: Studies included in this review examined the connection between cannabis and the cornea, more specifically anti-nociceptive and anti-inflammatory actions of cannabinoids. NCBI Databases from 1781 up to December 2019 were consulted.: Five studies examined corneal dysfunctions caused by cannabis consumption (opacification, decreased endothelial cell density). Twelve studies observed a reduction in corneal pain and inflammation (less lymphocytes, decreased corneal neovascularization, increased cell proliferation and migration).: More than half of the studies examined the therapeutic effects of cannabinoids on the cornea. As the field is still young, more studies should be conducted to develop safe cannabinoid treatments for corneal diseases.
虽然大麻有减轻角膜疼痛的潜力,但大麻素可能会引发副作用。这篇综述文章探讨了大麻素对角膜的影响。随着越来越多的州和国家考虑将成年人使用大麻合法化,医疗保健提供者将需要确定大麻消费对眼睛的影响。:本综述纳入的研究考察了大麻与角膜之间的联系,更具体地说是大麻素的抗伤害感受和抗炎作用。查阅了1781年至2019年12月的NCBI数据库。:五项研究考察了大麻消费导致的角膜功能障碍(浑浊、内皮细胞密度降低)。十二项研究观察到大麻对角膜疼痛和炎症有减轻作用(淋巴细胞减少、角膜新生血管形成减少、细胞增殖和迁移增加)。:超过一半的研究考察了大麻素对角膜的治疗作用。由于该领域仍处于起步阶段,应该开展更多研究来开发用于治疗角膜疾病的安全大麻素疗法。